A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy
Clinical trial NCT05938023 · TERMINATED
Trial details
- NCT number
- NCT05938023
- Sponsor
- Percheron Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-18
- Primary completion
- 2024-11-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.